AzTrials
AzTrials

Anastomotic Leak Large IntestineNCT06273826

"Colorectal Leakage App" for Early Detection of Anastomotic Leakage After Colorectal Surgeries

An observational study of Anastomotic Leak Large Intestine and Anastomotic Leak Rectum, run by National Research Oncology and Transplantology Center, Kazakhstan at 1 site in Kazakhstan.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The aim of this prospective observational study is to evaluate the effectiveness of the mobile application "Colorectal Leakage App" in the early diagnosis of anastomotic leakage after colorectal surgeries at the National Research Oncology Center in Astana, Kazakhstan. Main Questions: 1. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
"Colorectal Leakage App"
How many people
120 participants
Where
1 siteKazakhstan
Study dates
19 Jan 2024to May 2025
How long will I take part?
1 Year
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Scheduled patients with benign and malignant colorectal diseases undergoing surgical treatment, including the creation of anastomoses (ileocolic, colocolic, colorectal anastomoses), with or without a preventive stoma.

Who may be able to join

  • Scheduled patients with benign and malignant colorectal diseases undergoing surgical treatment, including the creation of anastomoses (ileocolic, colocolic, colorectal anastomoses), with or without a preventive stoma.
  • Male and female patients aged 18 years and older.
  • ECOG = 0-2; 6. Satisfactory hematological indicators and parameters of liver and kidney function.

Who cannot join

  • Participants under 18 years old.
  • Pregnant, lactating, or planning pregnancy participants.
  • ECOG>2;
  • Unresctable tumors.
  • Patient's refusal to continue participating in the study..

Trial locations and contacts

1 site in 1 country.

Saule Khamzina, MD contact

+77757172961

khamzina.saule88@gmail.com

Arman Kozhakhmetov, MD contact

+77772714801

a.kozhakhmetov@nu.edu.kz

Kazakhstan1 site, 1 recruiting
  • National Research Oncology Center

    Astana, 010000

    Saule Khamzina, MD, +77757172961, khamzina.saule88@gmail.com

    Recruiting

Other trials in Kazakhstan

About this study

Official title: The Implementation of the Mobile Application "Colorectal Leakage App", Based on the Dutch Leakage Score, for Early Detection of Anastomotic Leakage After Colorectal Surgeries

The aim of this prospective observational study is to evaluate the effectiveness of the mobile application "Colorectal Leakage App" in the early diagnosis of anastomotic leakage after colorectal surgeries at the National Research Oncology Center in Astana, Kazakhstan.

Main Questions:

Read more
  1. Development, validation, and implementation of the mobile application "Colorectal Leakage App," based on the Dutch Leakage Score.
  2. Evaluate the diagnostic effectiveness of the application in detecting anastomotic leakage after colorectal surgeries.
  3. Determine the frequency of anastomotic leakage after colorectal surgeries performed in the colorectal surgery sector of the National Research Oncology Center in the Astana city.

Participants in the study, individuals aged 18 and above undergoing colorectal surgeries, will be monitored by the mobile application "Colorectal Leakage App" in the postoperative period for early identification of anastomotic leakage.

Read the detailed description

Colorectal cancer ranks third among oncological diseases in Kazakhstan, both in men and women. Anastomotic leakage (AL) following colorectal surgeries is one of the most serious complications arising from colorectal surgical interventions. This condition is characterized by increased mortality and significant deterioration in the quality of life of patients. Additionally, the presence of AL after anterior resections for rectal cancer is associated with an increased risk of local disease recurrence. The frequency of AL varies between 2 and 19%, depending on risk factors, AL definition, and the level of anastomosis. Given the high likelihood and severe consequences of AL, a relevant task is its early detection and effective treatment.

Clinical signs of AL traditionally include fever, tachycardia, pain syndrome, purulent or fecal discharge through drainage, and dynamic bowel obstruction. These signs, combined with other clinical data, are integrated into a diagnostic-specific indicator known as the Dutch Leakage Score (DLS). This indicator is used as a standardized postoperative monitoring protocol for patients suspected of having AL, aiming to minimize delays in detecting this complication and, consequently, reduce early postoperative mortality.

In this prospective observational study, we aim to assess the effectiveness of the mobile application "Colorectal Leakage App" in the early detection of anastomotic leakage (AL) after colorectal surgeries. The study will be conducted at the National Research Oncology Center (NROC) in Astana, Kazakhstan, over one year. The primary goal is to evaluate the diagnostic effectiveness of the application in detecting AL after colorectal surgeries.

It is important to note that there is currently no up-to-date data on the number of colorectal cancer surgeries performed, and information on the frequency of AL after colorectal surgeries in the population of Kazakhstan is also lacking. Previous studies have shown that the effectiveness of the DLS algorithm is directly proportional to the frequency of AL. Therefore, it is assumed that the application of DLS may demonstrate different results in the conditions of Kazakhstan, which we also plan to measure through the "Colorectal Leakage App" mobile application.

  1. Design of the study: Prospective observational study, where the "Colorectal Leakage App" mobile application will be implemented in daily postoperative monitoring. Additionally, an assessment of the diagnostic effectiveness of this application will be conducted.
  2. Instruments and equipment:

The "Colorectal Leakage App" is a mobile application that, based on an algorithm, provides an assessment of the risk of Anastomotic Leakage (AL) in patients after colorectal surgeries. The algorithm is built on the standardized postoperative monitoring protocol called "Dutch Leakage Score". After calculating the scores, the application provides recommendations for further actions.

Primary endpoints:

  1. Sensitivity, Specificity, Positive Predictive Value, Negative Predictive Value.
  2. Frequency of AL after colorectal surgeries

Secondary endpoints:

  1. Mortality within 30 days:.
  2. Delay in the diagnosis of AL (number of days from the onset of the first signs of a leakage to the diagnosis of AL)
  3. Duration of hospital stay.
  4. Number of days in the ICU.
  5. Number of days between surgery and detection of AL.

Postoperative monitoring with the "Colorectal Leakage App":

It is planned to implement standardized postoperative monitoring for patients who have undergone colorectal surgeries using the "Colorectal Leakage App." The application will include an algorithm based on the Dutch Leakage Score indicator. Each postoperative day, data entry at the patient's bedside will be carried out in the application.

  1. Fever
  2. Heart rate
  3. Respiratory rate
  4. Urinary production
  5. Mental status
  6. Clinical condition
  7. Signs of ileus
  8. Gastric retention
  9. Fascial dehiscence
  10. Abdominal pain, other than
  11. wound pain
  12. Increased leukocyte count, C-reactive protein (CRP), creatinine, and urea.
  13. Nutritional status Based on the data analysis, the algorithm will provide recommendations regarding the necessity of conducting a computer tomography with rectal contrast.

The following information will also be collected: Preoperative risk factors for AL(age, gender, obesity, nutritional status, diabetes, cardiovascular diseases, renal insufficiency, inflammatory bowel diseases, ASAscore, bowel preparation); Surgery data (access, surgery type, anastomosis technique, duration of surgery, blood loss volume, formation of a preventive stoma, intraoperative and postoperative complications, pTNM).

Key points determining the conclusion of a patient's participation in the study will be: the detection of AL, patient discharge from the hospital, or patient death.

Being tested
"Colorectal Leakage App"
Keywords
Anastomotic Leak, Colorectal surgery, Mobile application, Dutch Leakage Score
Medical subject headings
Anastomotic Leak

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • "Colorectal Leakage App"Diagnostic test

    The "Colorectal Leakage App" is a mobile application designed to aid in the early detection of anastomotic insufficiency after colorectal surgeries. The app is based on the Dutch Leakage Score (DLS) algorithm, which is a standardized protocol for postoperative monitoring.

Study groups in NCT06273826
Study groupRoleWhat they receive
Colorectal Leakage App groupThis group comprises patients who will be monitored using the "Colorectal Leakage App" based on the Dutch leakage score for early detection of anastomotic insufficiency after colorectal surgeries.
Receives: Diagnostic Test: "Colorectal Leakage App"

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Diagnostic effectiveness of "Colorectal Leakage App".

    Measurement of sensitivity, specificity, positive predictive value and negative predictive value of the mobile application "Colorectal Leakage App".

    Measured: 1 year

  2. Frequency of anastomotic leakage after colorectal surgeries.

    Measurement of frequency of anastomotic leakage after colorectal surgeries at the National Research Oncology Center (NROC) in Astana, Kazakhstan.

    Measured: 1 year

Secondary outcomes (5)
  1. Mortality within 30 days

    Mortality within 30 days

    Measured: 1 year

  2. Delay in the diagnosis of anastomotic leakage

    Number of days from the onset of the first signs of a leakage to the diagnosis of anastomotic leakage..

    Measured: 1 year

  3. Duration of hospital stay.

    Duration of hospital stay.

    Measured: 1 year

  4. Number of days in the ICU.

    Number of days in the ICU.

    Measured: 1 year

  5. Number of days between surgery and detection of AL.

    Number of days between surgery and detection of AL.

    Measured: 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Feb 2024
  2. Study start19 Jan 2024
  3. Primary completionJan 2025 (estimated)
  4. Study completionMay 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
120 participants (estimated)
Target duration
1 Year
IDs, dates and publications
ClinicalTrials.gov ID
NCT06273826
Sponsor's protocol ID
01
Status last verified
Feb 2024
First submitted
15 Feb 2024
Last updated
23 Feb 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Jutesten H, Buchwald PL, Angenete E, Rutegard M, Lydrup ML. High Risk of Low Anterior Resection Syndrome in Long-term Follow-up After Anastomotic Leakage in Anterior Resection for Rectal Cancer. Dis Colon Rectum. 2022 Oct 1;65(10):1264-1273. doi: 10.1097/DCR.0000000000002334. Epub 2021 Dec 15.

    PubMed 35482994
  • Mirnezami A, Mirnezami R, Chandrakumaran K, Sasapu K, Sagar P, Finan P. Increased local recurrence and reduced survival from colorectal cancer following anastomotic leak: systematic review and meta-analysis. Ann Surg. 2011 May;253(5):890-9. doi: 10.1097/SLA.0b013e3182128929.

    PubMed 21394013
  • Akasu T, Takawa M, Yamamoto S, Yamaguchi T, Fujita S, Moriya Y. Risk factors for anastomotic leakage following intersphincteric resection for very low rectal adenocarcinoma. J Gastrointest Surg. 2010 Jan;14(1):104-11. doi: 10.1007/s11605-009-1067-4. Epub 2009 Oct 20.

    PubMed 19841989
  • Thornton M, Joshi H, Vimalachandran C, Heath R, Carter P, Gur U, Rooney P. Management and outcome of colorectal anastomotic leaks. Int J Colorectal Dis. 2011 Mar;26(3):313-20. doi: 10.1007/s00384-010-1094-3. Epub 2010 Nov 25.

    PubMed 21107847
  • Kang CY, Halabi WJ, Chaudhry OO, Nguyen V, Pigazzi A, Carmichael JC, Mills S, Stamos MJ. Risk factors for anastomotic leakage after anterior resection for rectal cancer. JAMA Surg. 2013 Jan;148(1):65-71. doi: 10.1001/2013.jamasurg.2.

    PubMed 22986932
  • Boccola MA, Lin J, Rozen WM, Ho YH. Reducing anastomotic leakage in oncologic colorectal surgery: an evidence-based review. Anticancer Res. 2010 Feb;30(2):601-7.

    PubMed 20332477
  • Kingham TP, Pachter HL. Colonic anastomotic leak: risk factors, diagnosis, and treatment. J Am Coll Surg. 2009 Feb;208(2):269-78. doi: 10.1016/j.jamcollsurg.2008.10.015. Epub 2008 Dec 4. No abstract available.

    PubMed 19228539
  • den Dulk M, Noter SL, Hendriks ER, Brouwers MA, van der Vlies CH, Oostenbroek RJ, Menon AG, Steup WH, van de Velde CJ. Improved diagnosis and treatment of anastomotic leakage after colorectal surgery. Eur J Surg Oncol. 2009 Apr;35(4):420-6. doi: 10.1016/j.ejso.2008.04.009. Epub 2008 Jun 27.

    PubMed 18585889

Questions about this trial

What is this clinical trial studying?

An observational study of Anastomotic Leak Large Intestine and Anastomotic Leak Rectum, run by National Research Oncology and Transplantology Center, Kazakhstan at 1 site in Kazakhstan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 23 Feb 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Kazakhstan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Saule Khamzina, MD (+77757172961, khamzina.saule88@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Diagnostic effectiveness of "Colorectal Leakage App". (time frame: 1 year). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06273826, which also lists 8 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Feb 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in